- Home
- LPCN vs SHFS Comparison
LPCN vs SHFS Comparison
Compare LPCN & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SHFS
- Stock Information
- Founded
- LPCN 1997
- SHFS 2015
- Country
- LPCN United States
- SHFS United States
- Employees
- LPCN N/A
- SHFS N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SHFS Finance: Consumer Services
- Sector
- LPCN Health Care
- SHFS Finance
- Exchange
- LPCN Nasdaq
- SHFS Nasdaq
- Market Cap
- LPCN 19.4M
- SHFS 20.8M
- IPO Year
- LPCN N/A
- SHFS N/A
- Fundamental
- Price
- LPCN $3.38
- SHFS $0.37
- Analyst Decision
- LPCN Strong Buy
- SHFS
- Analyst Count
- LPCN 1
- SHFS 0
- Target Price
- LPCN $10.00
- SHFS N/A
- AVG Volume (30 Days)
- LPCN 33.0K
- SHFS 118.1K
- Earning Date
- LPCN 03-06-2025
- SHFS 03-31-2025
- Dividend Yield
- LPCN N/A
- SHFS N/A
- EPS Growth
- LPCN N/A
- SHFS N/A
- EPS
- LPCN N/A
- SHFS 0.10
- Revenue
- LPCN $7,922,926.00
- SHFS $15,658,629.00
- Revenue This Year
- LPCN N/A
- SHFS N/A
- Revenue Next Year
- LPCN N/A
- SHFS N/A
- P/E Ratio
- LPCN N/A
- SHFS $3.65
- Revenue Growth
- LPCN N/A
- SHFS 7.78
- 52 Week Low
- LPCN $3.20
- SHFS $0.30
- 52 Week High
- LPCN $11.79
- SHFS $1.01
- Technical
- Relative Strength Index (RSI)
- LPCN 30.99
- SHFS 37.36
- Support Level
- LPCN $3.42
- SHFS $0.38
- Resistance Level
- LPCN $3.62
- SHFS $0.44
- Average True Range (ATR)
- LPCN 0.26
- SHFS 0.03
- MACD
- LPCN -0.02
- SHFS -0.01
- Stochastic Oscillator
- LPCN 1.61
- SHFS 2.73
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.